Rahul M. Kohli, MD, PhD
Infectious Diseases
Accepting new patients
Sees patients age 18 and up
Penn Medicine Provider
About me
- Professor of Medicine (Infectious Diseases)
- Professor of Biochemistry and Biophysics
My education and training
- Medical School: Harvard Medical School
- Residency: University of Pennsylvania Health System
- Fellowship: Johns Hopkins Hospital
Spoken languages
English
English
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Qualifications and experience
- Infectious Disease, 2009
- American Associate of Physicians (AAP), National
- American Association for the Advancement of Science, National
- American Chemical Society, National
- American Society for Clinical Investigation, National
- Infectious Disease Society of America, National
- Interurban Clinical Club, National
- National Institutes of Health, National
Treatments and conditions
Research
Publications
Schutsky EK, DeNizio JE, Hu P, Liu MY, Nabel CS, Fabyanic EB, Hwang Y, Bushman FD, Wu H, Kohli RM Nondestructive, base-resolution sequencing of 5-hydroxymethylcytosine using a DNA deaminase , Nature Biotech, 8(10): 2018,1083–1090
DeNizio JE, Liu MY, Leddin EM, Cisneros GA, Kohli RM Selectivity and Promiscuity in TET-Mediated Oxidation of 5-Methylcytosine in DNA and RNA , Biochemistry, 58(5): 2019,411-421
Samuels AN, Roggiani M, Zhu J, Goulian M, Kohli RM The SOS Response Mediates Sustained Colonization of the Mammalian Gut , Infection and Immunity, 87(2): 2019,e00711-18
Ghanty U, DeNizio JE, Liu MY, Kohli RM Exploiting Substrate Promiscuity to Develop Activity-Based Probes for TET Family Enzymes , J Am Chem Soc, 140(50): 2018,17329-17332
Selwood T, Larsen BJ, Mo CY, Culyba MJ, Hostetler ZM, Kohli RM, Reitz AB, Baugh SDP. Advancement of the 5-Amino-1-(Carbamoylmethyl)-1H-1,2,3-Triazole-4-Carboxamide Scaffold to Disarm the Bacterial SOS Response. , Frontiers in Microbiology, 9(1): 2018,2961
Hrit J, Goodrich L, Li C, Wang BA, Nie J, Cui X, Martin EA, Simental E, Fernandez J, Liu MY, Nery JR, Castanon R, Kohli RM, Tretyakova N, He C, Ecker JR, Goll M, Panning B OGT binds a conserved C-terminal domain of TET1 to regulate TET1 activity and function in development , Elife, 7(1): 2018,e34870
Hostetler ZM, Ferrie JJ, Bornstein MR, Sungwienwong I, Petersson EJ, Kohli RM Systematic Evaluation of Soluble Protein Expression Using a Fluorescent Unnatural Amino Acid Reveals No Reliable Predictors of Tolerability , ACS Chem Bio, 13(10): 2018,2855-2861
Sungwienwong I, Ferrie JJ, Jun JV, Liu C, Barrett TM, Hostetler ZM, Ieda N, Hendricks A, Muthusamy AK, Kohli RM, Chenoweth DM, Petersson GA, Petersson EJ Improving the fluorescent probe acridonylalanine through a combination of theory and experiment , J Phys Org Chen, 31(8): 2018,e3813
Fraietta JA, Nobles CL, Sammons MA, Lundh S, Carty SA, Reich TJ, Cogdill AP, Morrissette JJD, DeNizio JE, Reddy S, Hwang Y, Gohil M, Kulikovskaya I, Nazimuddin F, Gupta M, Chen F, Everett JK, Alexander KA, Lin-Shiao E, Gee MH, Liu X, Young RM, Ambrose D, Wang Y, Xu J, Jordan MS, Marcucci KT, Levine BL, Garcia KC, Zhao Y, Kalos M, Porter DL, Kohli RM, Lacey SF, Berger SL, Bushman FD, June CH, Melenhorst JJ Disruption of TET2 Promotes the Therapeutic Efficacy of CD19-targeted T cells , Nature, 558(7709): 2018,307-312